ApoC[III] You Later: A Review of Plozasiran for the Management of Familial Chylomicronemia Syndrome

ANNALS OF PHARMACOTHERAPY · Published 2026-06-06 · DOI 10.1177/10600280261452675

Free full text

Authors (3)

Ellen B. Yin, Matthew A. Wanat, Elisabeth M. Wang

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Yin, E., Wanat, M., Wang, E. (2026). ApoC[III] You Later: A Review of Plozasiran for the Management of Familial Chylomicronemia Syndrome. ANNALS OF PHARMACOTHERAPY. https://doi.org/10.1177/10600280261452675

Related articles

• Insulin Glargine Use in Dexamethasone-Induced Hyperglycemia: A Retrospective Cohort Analysis · ANNALS OF PHARMACOTHERAPY · 2026 · Same journal
• The Need for Better Stewardship of Medication Use in Older Adults · ANNALS OF PHARMACOTHERAPY · 2026 · Same journal
• Description of Treatment Strategies and Patient Outcomes for Hospitalized Patients With Lyme Carditis · ANNALS OF PHARMACOTHERAPY · 2026 · Same journal
• Four-Year Evaluation of a Pharmacists-Providers Collaborative Iron Deficiency Clinic in Heart Failure Care · ANNALS OF PHARMACOTHERAPY · 2026 · Same journal
• Comment on “Safety and Efficacy of the Prescribing Practices of Ketamine for Pain and Agitation in the Medical Intensive Care Unit” · ANNALS OF PHARMACOTHERAPY · 2026 · Same journal
• Prognostic Value of Mean Platelet Volume-To-Monocyte Ratio and Ferritin in NSTEMI: Independent Impact of Angiotensin-Converting Enzyme Inhibitor Therapy · ANNALS OF PHARMACOTHERAPY · 2026 · Same journal
• Process Improvement Is Not Yet Long-Term Effectiveness: Interpreting a Pharmacist-Provider Iron Deficiency Clinic · ANNALS OF PHARMACOTHERAPY · 2026 · Same journal
• Severe Phototoxic Skin Reaction Associated With Vandetanib: Implications for Pharmaceutical Care · ANNALS OF PHARMACOTHERAPY · 2026 · Same journal
• Low-Dose Oral Ketamine for Pain Management: A Primer for Clinicians · ANNALS OF PHARMACOTHERAPY · 2026 · Same journal
• Impact on Vulnerable Populations After Discontinuation of Continuous Glucose Monitoring in Patients With Type 2 Diabetes · ANNALS OF PHARMACOTHERAPY · 2026 · Same journal